Brief: Essex Bio-Technology Announces Product Interests Transfer Agreement With Parkson Pharmaceutical
June 9 (Reuters) - Essex Bio-Technology Ltd 1061.HK :
* ANNOUNCES PRODUCT INTERESTS TRANSFER AGREEMENT BETWEEN
UNIT &
PARKSON PHARMACEUTICAL
* AGREEMENT FOR POSSIBLE ACQUISITION BY UNIT OF IP RIGHTS OF
A
MEDICINAL PRODUCT IN CAPSULE FORM, IODIZED LECITHIN CAPSULES
* POSSIBLE ACQUISITION FOR RMB97 MILLION
Further company coverage: 1061.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Essex Bio-Technology
See all newsHong Kong's Essex Bio-Technology H1 revenue falls
Brief: Essex Bio-Technology Posts HY Profit Of HK$110.7 MLN
Brief: Essex Bio-Technology Expects 10% Revenue And 30% Profit Decrease For HY
Brief: Shanghai Henlius Biotech Says Phase 3 Study Of HLX04-O For WAMD Meets Primary Endpoint
Brief: Essex Bio-Technology Posts Final Dividend Of HK$0.07 Per Share